Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with Chemo-Radiotherapy in Locally Advanced NSCLC
NCT02115464Phase 2Terminated
- Sponsor
- Ontario Clinical Oncology Group
- Start
- Dec 2014
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in non-small cell lung cancer (NSCLC), sponsored by Ontario Clinical Oncology Group. Started Dec 2014; status: terminated.
02
Drugs
metformin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02115464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115464.